By end-user, the pharmaceutical industries segment held around three-fourths of the global formulation development outsourcing market share in 2021, and is projected to dominate by 2031. The same segment would also cite the fastest CAGR of 9.3% from 2022 to 2031. The fact that pharmaceutical industries provide medicines for the individual treatment of various types of diseases propels the growth of the segment.
Rise in demand for biopharmaceuticals and advanced drug delivery systems drives the growth of the global formulation development outsourcing market. However, structural changes in the pharmaceutical sector and lack of funds to complete the medication development process through formulation development restrain the market growth to some extent. On the other hand, global awareness of vaccines and extensive R&D works have paved the way for lucrative opportunities for the key players in the industry.
By services type, the formulation development segment held the major share in 2021, accounting for more than half of the global formulation development outsourcing market revenue. This is because formulation development plays a crucial role in creating stable and patient-acceptable drug preparations and forms. The pre-formulation segment, on the other hand, would showcase the fastest CAGR of 9.2% during the forecast period. This is due to the fact that in pre-formulation, the physicochemical qualities of drug materials are described which ease the research process.
By end-user, the pharmaceutical industries segment held around three-fourths of the global formulation development outsourcing market share in 2021, and is projected to dominate by 2031. The same segment would also cite the fastest CAGR of 9.3% from 2022 to 2031. The fact that pharmaceutical industries provide medicines for the individual treatment of various types of diseases propels the growth of the segment.